← 返回

NR4a1/2 缺失促进肿瘤微环境中 TCF1(+) 干细胞样耗竭 CD8(+) T 细胞前体的积累

英文原题:NR4a1/2 deletion promotes accumulation of TCF1(+) stem-like precursors of exhausted CD8(+) T cells in the tumor microenvironment.

查看英文原题

NR4a1/2 deletion promotes accumulation of TCF1(+) stem-like precursors of exhausted CD8(+) T cells in the tumor microenvironment.

PubMed 2024/03/06(内容时间) Cell Rep Q1 · IF 7.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

T细胞耗竭会损害肿瘤免疫并导致对免疫检查点抑制剂的耐药。核受体亚家族4A组(NR4a)核受体家族在驱动T细胞耗竭中发挥关键作用。在本研究中,我们观察到CD8+TIL(肿瘤浸润淋巴细胞)(TILs)中NR4a1和NR4a2缺陷可导致强效的肿瘤清除,并且不仅表现出耗竭特征减少,还表现出耗竭T细胞前体/祖细胞(Pre-Tex)细胞比例增加。将NR4a1-/-NR4a2-/-CD8+TILs连续过继转移至荷瘤小鼠中,可导致TCF1+(Tcf7+)干细胞样Pre-Tex细胞扩增,而野生型TILs在二次转移后被耗竭。NR4a1/2缺陷的CD8+T细胞表达更高水平的干性/记忆相关基因,并表现出强效的线粒体氧化磷酸化。总体而言,这些发现表明,在肿瘤中抑制NR4a通过增加干细胞样Pre-Tex细胞并减少CD8+T细胞耗竭,代表了一种强效的免疫肿瘤治疗策略。

展开英文摘要原文

T cell exhaustion impairs tumor immunity and contributes to resistance against immune checkpoint inhibitors. The nuclear receptor subfamily 4 group A (NR4a) family of nuclear receptors plays a crucial role in driving T cell exhaustion. In this study, we observe that NR4a1 and NR4a2 deficiency in CD8 + tumor-infiltrating lymphocytes (TILs) results in potent tumor eradication and exhibits not only reduced exhaustion characteristics but also an increase in the precursors/progenitors of exhausted T (Pre-Tex) cell fraction.

Serial transfers of NR4a1 -/- NR4a2 -/- CD8 + TILs into tumor-bearing mice result in the expansion of TCF1 + (Tcf7 + ) stem-like Pre-Tex cells, whereas wild-type TILs are depleted upon secondary transfer. NR4a1/2-deficient CD8 + T cells express higher levels of stemness/memory-related genes and illustrate potent mitochondrial oxidative phosphorylation. Collectively, these findings suggest that inhibiting NR4a in tumors represents a potent immuno-oncotherapy strategy by increasing stem-like Pre-Tex cells and reducing exhaustion of CD8 + T cells.

论文信息

作者
Srirat T、Hayakawa T、Mise-Omata S、Nakagawara K、Ando M、Shichino S、Ito M、Yoshimura A
第一作者单位
Department of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: st.srirat@gmail.com.Japan
通讯作者单位
Department of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: yoshimura@keio.jp.Japan
文献类型
非美国政府资助研究
期刊
Cell reports2024 Mar 26
原文标识
PubMed 38451819 · DOI 10.1016/j.celrep.2024.113898